Our previous results showed that cloned 6D cells acquired resistance to doxorubicin and tamoxifen, together with other features of aggressive cancer cells, through an EMT program induced by activation of the IL-1β/IL-1RI/β-catenin pathway [4,5,6]. The gene discussed is IL1B; the disease is cancer.